In the current study, we demonstrate PDLIM2 expression was inhibited in both ovarian high-grade serous carcinoma and in several human ovarian cancer cell lines compared to normal ovarian tissues and human ovarian surface epithelial cells (HOSE). The gene discussed is PDLIM2; the disease is ovarian cancer.